Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | -0.59% | -1.17% | -24.89% |
03-21 | Stifel Cuts Price Target on Vor Biopharma to $12 From $15, Maintains Buy Rating | MT |
03-21 | Oppenheimer Cuts Vor Biopharma Price Target to $15 From $18, Maintains Outperform Rating | MT |
Sales 2024 * | - | Sales 2025 * | 1.43M 114M | Capitalization | 115M 9.22B |
---|---|---|---|---|---|
Net income 2024 * | -102M -8.15B | Net income 2025 * | -115M -9.19B | EV / Sales 2024 * | - |
Net Debt 2024 * | 16.29M 1.3B | Net cash position 2025 * | 52.11M 4.17B | EV / Sales 2025 * | 44.2 x |
P/E ratio 2024 * |
-1.22
x | P/E ratio 2025 * |
-1.25
x | Employees | 168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.83% |
1 day | -0.59% | ||
1 week | -1.17% | ||
Current month | -28.69% | ||
1 month | -28.69% | ||
3 months | -27.78% | ||
6 months | -19.52% | ||
Current year | -24.89% |
Managers | Title | Age | Since |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 06/08/19 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 30/04/20 |
Chief Tech/Sci/R&D Officer | 51 | 30/09/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 29/07/20 |
Matt Patterson
CHM | Chairman | 52 | 19/10/20 |
Bob Ang
CEO | Chief Executive Officer | 49 | 06/08/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.69 | -0.59% | 154,391 |
25/04/24 | 1.7 | -2.30% | 181,018 |
24/04/24 | 1.74 | -7.45% | 287,032 |
23/04/24 | 1.88 | +3.30% | 209,685 |
22/04/24 | 1.82 | +6.43% | 232,177 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.89% | 115M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VOR Stock